In Vitro Study to Evaluate the Best Conditions Highlighting the Antimicrobial Activity of Carum carvi Essential Oil on Human Pathogen Isolates in Formulations Against the Spread of Antibiotic Resistance

Background/Objectives: In recent years, antimicrobial resistance has become a major threat to global health, and scientific research aiming to identify new therapeutic resources is a priority. Essential oils (EOs), obtained from spices belonging to the culinary tradition, like Carum carvi essential...

Full description

Saved in:
Bibliographic Details
Published inPharmaceuticals (Basel, Switzerland) Vol. 18; no. 3; p. 321
Main Authors Mastrella, Carolina, Rizzo, Silvia, Vito, Maura Di, Garzoli, Stefania, Mercurio, Mattia Di, Mariotti, Melinda, La Sorda, Marilena, Zhiri, Abdesselam, Sanguinetti, Maurizio, Bugli, Francesca
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 25.02.2025
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background/Objectives: In recent years, antimicrobial resistance has become a major threat to global health, and scientific research aiming to identify new therapeutic resources is a priority. Essential oils (EOs), obtained from spices belonging to the culinary tradition, like Carum carvi essential oil (CC-EO), are of great interest for their antimicrobial activity, but the methods used to evaluate their efficacy need to be standardized. The aims of this work were to evaluate the following: (i) the best microbiological in vitro test; (ii) the best surfactant; and (iii) the best microbiological target of CC-EO and its method of administration. Methods: CC-EO quality was evaluated using gas chromatography–mass spectrometry. Antimicrobial susceptibility testing with drugs currently in use was performed. Antimicrobial effectiveness against 70 clinical strains belonging to S. aureus, E. coli, E. faecalis, K. pneumoniae, P. aeruginosa, S. pyogenes, and C. albicans was evaluated. Two microbial tests (broth microdilution tests and disk diffusion), generally used in routine clinical practice, were compared. To choose the best vehicle, Tween80, DMSO, and ethanol were evaluated. The antimicrobial efficacy of vapors was assessed using a microatmosphere test. Results: The broth microdilution test is confirmed as the best in evaluating the antimicrobial activity of EOs. The most suitable EOs vehicle for antimicrobial testing was Tween80. CC-EO and its vapors were effective against GRAM+ and C. albicans strains, both sensible and resistant, and ineffective against GRAM−. Conclusions: In the future, it may be possible to include CC-EO in topical or spray formulations for the treatment of GRAM+ and C. albicans infections.
AbstractList Background/Objectives : In recent years, antimicrobial resistance has become a major threat to global health, and scientific research aiming to identify new therapeutic resources is a priority. Essential oils (EOs), obtained from spices belonging to the culinary tradition, like Carum carvi essential oil (CC-EO), are of great interest for their antimicrobial activity, but the methods used to evaluate their efficacy need to be standardized. The aims of this work were to evaluate the following: (i) the best microbiological in vitro test; (ii) the best surfactant; and (iii) the best microbiological target of CC-EO and its method of administration. Methods : CC-EO quality was evaluated using gas chromatography–mass spectrometry. Antimicrobial susceptibility testing with drugs currently in use was performed. Antimicrobial effectiveness against 70 clinical strains belonging to S. aureus , E. coli , E. faecalis , K. pneumoniae , P. aeruginosa , S. pyogenes , and C. albicans was evaluated. Two microbial tests (broth microdilution tests and disk diffusion), generally used in routine clinical practice, were compared. To choose the best vehicle, Tween80, DMSO, and ethanol were evaluated. The antimicrobial efficacy of vapors was assessed using a microatmosphere test. Results : The broth microdilution test is confirmed as the best in evaluating the antimicrobial activity of EOs. The most suitable EOs vehicle for antimicrobial testing was Tween80. CC-EO and its vapors were effective against GRAM+ and C. albicans strains, both sensible and resistant, and ineffective against GRAM−. Conclusions : In the future, it may be possible to include CC-EO in topical or spray formulations for the treatment of GRAM+ and C. albicans infections.
Background/Objectives: In recent years, antimicrobial resistance has become a major threat to global health, and scientific research aiming to identify new therapeutic resources is a priority. Essential oils (EOs), obtained from spices belonging to the culinary tradition, like Carum carvi essential oil (CC-EO), are of great interest for their antimicrobial activity, but the methods used to evaluate their efficacy need to be standardized. The aims of this work were to evaluate the following: (i) the best microbiological in vitro test; (ii) the best surfactant; and (iii) the best microbiological target of CC-EO and its method of administration. Methods: CC-EO quality was evaluated using gas chromatography-mass spectrometry. Antimicrobial susceptibility testing with drugs currently in use was performed. Antimicrobial effectiveness against 70 clinical strains belonging to S. aureus, E. coli, E. faecalis, K. pneumoniae, P. aeruginosa, S. pyogenes, and C. albicans was evaluated. Two microbial tests (broth microdilution tests and disk diffusion), generally used in routine clinical practice, were compared. To choose the best vehicle, Tween80, DMSO, and ethanol were evaluated. The antimicrobial efficacy of vapors was assessed using a microatmosphere test. Results: The broth microdilution test is confirmed as the best in evaluating the antimicrobial activity of EOs. The most suitable EOs vehicle for antimicrobial testing was Tween80. CC-EO and its vapors were effective against GRAM+ and C. albicans strains, both sensible and resistant, and ineffective against GRAM-. Conclusions: In the future, it may be possible to include CC-EO in topical or spray formulations for the treatment of GRAM+ and C. albicans infections.Background/Objectives: In recent years, antimicrobial resistance has become a major threat to global health, and scientific research aiming to identify new therapeutic resources is a priority. Essential oils (EOs), obtained from spices belonging to the culinary tradition, like Carum carvi essential oil (CC-EO), are of great interest for their antimicrobial activity, but the methods used to evaluate their efficacy need to be standardized. The aims of this work were to evaluate the following: (i) the best microbiological in vitro test; (ii) the best surfactant; and (iii) the best microbiological target of CC-EO and its method of administration. Methods: CC-EO quality was evaluated using gas chromatography-mass spectrometry. Antimicrobial susceptibility testing with drugs currently in use was performed. Antimicrobial effectiveness against 70 clinical strains belonging to S. aureus, E. coli, E. faecalis, K. pneumoniae, P. aeruginosa, S. pyogenes, and C. albicans was evaluated. Two microbial tests (broth microdilution tests and disk diffusion), generally used in routine clinical practice, were compared. To choose the best vehicle, Tween80, DMSO, and ethanol were evaluated. The antimicrobial efficacy of vapors was assessed using a microatmosphere test. Results: The broth microdilution test is confirmed as the best in evaluating the antimicrobial activity of EOs. The most suitable EOs vehicle for antimicrobial testing was Tween80. CC-EO and its vapors were effective against GRAM+ and C. albicans strains, both sensible and resistant, and ineffective against GRAM-. Conclusions: In the future, it may be possible to include CC-EO in topical or spray formulations for the treatment of GRAM+ and C. albicans infections.
Background/Objectives: In recent years, antimicrobial resistance has become a major threat to global health, and scientific research aiming to identify new therapeutic resources is a priority. Essential oils (EOs), obtained from spices belonging to the culinary tradition, like Carum carvi essential oil (CC-EO), are of great interest for their antimicrobial activity, but the methods used to evaluate their efficacy need to be standardized. The aims of this work were to evaluate the following: (i) the best microbiological in vitro test; (ii) the best surfactant; and (iii) the best microbiological target of CC-EO and its method of administration. Methods: CC-EO quality was evaluated using gas chromatography–mass spectrometry. Antimicrobial susceptibility testing with drugs currently in use was performed. Antimicrobial effectiveness against 70 clinical strains belonging to S. aureus, E. coli, E. faecalis, K. pneumoniae, P. aeruginosa, S. pyogenes, and C. albicans was evaluated. Two microbial tests (broth microdilution tests and disk diffusion), generally used in routine clinical practice, were compared. To choose the best vehicle, Tween80, DMSO, and ethanol were evaluated. The antimicrobial efficacy of vapors was assessed using a microatmosphere test. Results: The broth microdilution test is confirmed as the best in evaluating the antimicrobial activity of EOs. The most suitable EOs vehicle for antimicrobial testing was Tween80. CC-EO and its vapors were effective against GRAM+ and C. albicans strains, both sensible and resistant, and ineffective against GRAM−. Conclusions: In the future, it may be possible to include CC-EO in topical or spray formulations for the treatment of GRAM+ and C. albicans infections.
: In recent years, antimicrobial resistance has become a major threat to global health, and scientific research aiming to identify new therapeutic resources is a priority. Essential oils (EOs), obtained from spices belonging to the culinary tradition, like essential oil (CC-EO), are of great interest for their antimicrobial activity, but the methods used to evaluate their efficacy need to be standardized. The aims of this work were to evaluate the following: (i) the best microbiological in vitro test; (ii) the best surfactant; and (iii) the best microbiological target of CC-EO and its method of administration. : CC-EO quality was evaluated using gas chromatography-mass spectrometry. Antimicrobial susceptibility testing with drugs currently in use was performed. Antimicrobial effectiveness against 70 clinical strains belonging to , , , , , , and was evaluated. Two microbial tests (broth microdilution tests and disk diffusion), generally used in routine clinical practice, were compared. To choose the best vehicle, Tween80, DMSO, and ethanol were evaluated. The antimicrobial efficacy of vapors was assessed using a microatmosphere test. : The broth microdilution test is confirmed as the best in evaluating the antimicrobial activity of EOs. The most suitable EOs vehicle for antimicrobial testing was Tween80. CC-EO and its vapors were effective against GRAM+ and strains, both sensible and resistant, and ineffective against GRAM-. : In the future, it may be possible to include CC-EO in topical or spray formulations for the treatment of GRAM+ and infections.
Audience Academic
Author Vito, Maura Di
Mercurio, Mattia Di
La Sorda, Marilena
Rizzo, Silvia
Mariotti, Melinda
Zhiri, Abdesselam
Mastrella, Carolina
Garzoli, Stefania
Sanguinetti, Maurizio
Bugli, Francesca
AuthorAffiliation 4 R&D Department, Pranarom International, 37 Avenue des Artisans, 7822 Ghislenghien, Belgium; azhiri@pranarom.com
3 Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli 8, 00168 Rome, Italy; marilena.lasorda@policlinicogemelli.it
5 Plant Biotechnology, Université Libre de Bruxelles (ULB), CP300, Rue Prof. Jeener & Brachet 12, 6041 Gosselies, Belgium
1 Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, 00168 Rome, Italy silvia.rizzo@unicatt.it (S.R.); mattia.dimercurio@unicatt.it (M.D.M.); melinda.mariotti@unicatt.it (M.M.); maurizio.sanguinetti@unicatt.it (M.S.); francesca.bugli@unicatt.it (F.B.)
2 Dipartimento di Chimica e Tecnologie del Farmaco, Università di Roma Sapienza, Piazzale Aldo Moro 5, 00185 Rome, Italy; stefania.garzoli@uniroma1.it
AuthorAffiliation_xml – name: 1 Dipartimento di Scienze Biotecnologiche di Base, Cliniche Intensivologiche e Perioperatorie, Università Cattolica del Sacro Cuore, 00168 Rome, Italy silvia.rizzo@unicatt.it (S.R.); mattia.dimercurio@unicatt.it (M.D.M.); melinda.mariotti@unicatt.it (M.M.); maurizio.sanguinetti@unicatt.it (M.S.); francesca.bugli@unicatt.it (F.B.)
– name: 3 Dipartimento di Scienze di Laboratorio e Infettivologiche, Fondazione Policlinico Universitario A. Gemelli IRCCS, Largo A. Gemelli 8, 00168 Rome, Italy; marilena.lasorda@policlinicogemelli.it
– name: 4 R&D Department, Pranarom International, 37 Avenue des Artisans, 7822 Ghislenghien, Belgium; azhiri@pranarom.com
– name: 2 Dipartimento di Chimica e Tecnologie del Farmaco, Università di Roma Sapienza, Piazzale Aldo Moro 5, 00185 Rome, Italy; stefania.garzoli@uniroma1.it
– name: 5 Plant Biotechnology, Université Libre de Bruxelles (ULB), CP300, Rue Prof. Jeener & Brachet 12, 6041 Gosselies, Belgium
Author_xml – sequence: 1
  givenname: Carolina
  surname: Mastrella
  fullname: Mastrella, Carolina
– sequence: 2
  givenname: Silvia
  orcidid: 0009-0000-6104-0282
  surname: Rizzo
  fullname: Rizzo, Silvia
– sequence: 3
  givenname: Maura Di
  orcidid: 0000-0002-2991-0855
  surname: Vito
  fullname: Vito, Maura Di
– sequence: 4
  givenname: Stefania
  orcidid: 0000-0001-8535-0533
  surname: Garzoli
  fullname: Garzoli, Stefania
– sequence: 5
  givenname: Mattia Di
  surname: Mercurio
  fullname: Mercurio, Mattia Di
– sequence: 6
  givenname: Melinda
  orcidid: 0000-0001-6901-0168
  surname: Mariotti
  fullname: Mariotti, Melinda
– sequence: 7
  givenname: Marilena
  surname: La Sorda
  fullname: La Sorda, Marilena
– sequence: 8
  givenname: Abdesselam
  surname: Zhiri
  fullname: Zhiri, Abdesselam
– sequence: 9
  givenname: Maurizio
  orcidid: 0000-0002-9780-7059
  surname: Sanguinetti
  fullname: Sanguinetti, Maurizio
– sequence: 10
  givenname: Francesca
  orcidid: 0000-0001-9038-3233
  surname: Bugli
  fullname: Bugli, Francesca
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40143099$$D View this record in MEDLINE/PubMed
BookMark eNptkl1r2zAUhs3oWD-2m_2AIdjNGKTTV2z5amQhXQOFjnXbrZBl2VGwpVSSA_mL-1U7Trq2GcMIW9Lj99U5es-zE-edybK3BF8yVuJPmxURmGFGyYvsjHDKJ4Ly4uTZ92l2HuMa42lBOHmVnXJMOMNleZb9Xjr0y6bg0V0a6h1KHi22qhtUMiitDPpiYkJz72qbrHcRXdt21cFI1rV7YOaS7a0OvrKqQzOd7NamHfINmqsw9EirsLVoEaMBEIhb2yHv0PXQK4e-qbTyrXFoGX0HlhFZh6586AeY7f1mrbIOjjBa3W2CUfUoPZpW1ier0XcTbUzKafM6e9moLpo3D--L7OfV4sf8enJz-3U5n91M9BSTNNFC16xUpmBFXVBSNrpSylChKi4Kjivd5EXO8nGTs7zKmRF13lDSNJRqUSp2kS0PurVXa7kJtldhJ72ycr_gQytVgKN1RjJTYTFtcsFFxVldg8kU2k5rVQq4OQxanw9am6HqTa2hSUF1R6LHO86uZOu3kpCST8tpAQofHhSCvx_gtmRvozZdp5zxQ5SMCCIoWFFA3_-Drv0QHPRqT-UEE5w_Ua2CCqxrPBjrUVTOBBOMEEwFUJf_oeCpDaQB8tlYWD_64d3zSh9L_BtFAD4eAMhSjME0jwjBcsy5fMo5-wPGhPDX
Cites_doi 10.3390/antibiotics9060346
10.3390/antibiotics11091215
10.1016/j.micpath.2019.103580
10.2174/0929867033457719
10.1080/09553002.2022.2078004
10.3390/jof3040057
10.3390/antibiotics12030591
10.1080/10408398.2017.1371112
10.3390/molecules26123625
10.1080/14786419.2021.1994566
10.1055/s-2006-962755
10.3390/antiox10020330
10.1021/jf0487351
10.1016/j.ijmm.2020.151435
10.1016/S0140-6736(21)02724-0
10.1080/87559129.2024.2357612
10.1038/s41579-022-00720-1
10.3390/foods12214017
10.4103/0973-7847.79101
10.1111/j.1469-0691.2011.03570.x
10.3390/antibiotics10040417
10.1093/infdis/jix131
ContentType Journal Article
Copyright COPYRIGHT 2025 MDPI AG
2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2025 by the authors. 2025
Copyright_xml – notice: COPYRIGHT 2025 MDPI AG
– notice: 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2025 by the authors. 2025
DBID AAYXX
CITATION
NPM
3V.
7XB
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
GNUQQ
GUQSH
M2O
MBDVC
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOA
DOI 10.3390/ph18030321
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
ProQuest Central (purchase pre-March 2016)
ProQuest Central (Alumni) (purchase pre-March 2016)
Research Library (Alumni)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
ProQuest Central
ProQuest Central Student
ProQuest Research Library
ProQuest Research Library
Research Library (Corporate)
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
Open Access资源_DOAJ
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Basic
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Central (Alumni Edition)
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Central China
ProQuest Central
ProQuest One Academic UKI Edition
ProQuest Central Korea
ProQuest Research Library
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
CrossRef
PubMed
Publicly Available Content Database


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1424-8247
ExternalDocumentID oai_doaj_org_article_3eb085f6848b43dd8ab50992da983900
PMC11945957
A838311028
40143099
10_3390_ph18030321
Genre Journal Article
GeographicLocations Italy
Europe
GeographicLocations_xml – name: Italy
– name: Europe
GrantInformation_xml – fundername: Ministero dell'università e della ricerca
  grantid: Project no. PE00000007, INF-ACT
– fundername: Università Cattolica del Sacro Cuore
  grantid: Linea D1
– fundername: EU
  grantid: PE00000007
GroupedDBID ---
2WC
53G
5VS
8G5
AADQD
AAFWJ
AAYXX
ABDBF
ABUWG
ACGFO
ACIHN
ACUHS
ADBBV
AEAQA
AFKRA
AFPKN
AFZYC
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BCNDV
BENPR
BPHCQ
CCPQU
CITATION
DIK
DWQXO
EBD
ESX
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
HH5
HYE
IAO
IHR
ITC
KQ8
M2O
M48
MK0
MODMG
M~E
OK1
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
RPM
TUS
NPM
PMFND
3V.
7XB
8FK
MBDVC
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c501t-c8cd39ae737d7219fcbaae28ab48740bcf676367d72436b63e8d6f21ff22c89a3
IEDL.DBID M48
ISSN 1424-8247
IngestDate Wed Aug 27 01:30:33 EDT 2025
Thu Aug 21 18:39:53 EDT 2025
Wed Jul 02 05:14:49 EDT 2025
Mon Jun 30 12:02:18 EDT 2025
Tue Jun 17 21:55:15 EDT 2025
Tue Jun 10 03:43:15 EDT 2025
Sun Mar 30 01:28:21 EDT 2025
Tue Jul 01 05:21:40 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords DMSO
antimicrobial resistance
broth microdilution test
Tween80
microatmosphere test
disk diffusion test
ethanol
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c501t-c8cd39ae737d7219fcbaae28ab48740bcf676367d72436b63e8d6f21ff22c89a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
These authors also contributed equatlly to this work.
These authors contributed equatlly to this work.
ORCID 0000-0001-8535-0533
0000-0002-2991-0855
0000-0001-9038-3233
0000-0001-6901-0168
0009-0000-6104-0282
0000-0002-9780-7059
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/ph18030321
PMID 40143099
PQID 3181610106
PQPubID 2032350
ParticipantIDs doaj_primary_oai_doaj_org_article_3eb085f6848b43dd8ab50992da983900
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11945957
proquest_miscellaneous_3181820032
proquest_journals_3181610106
gale_infotracmisc_A838311028
gale_infotracacademiconefile_A838311028
pubmed_primary_40143099
crossref_primary_10_3390_ph18030321
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2025-02-25
PublicationDateYYYYMMDD 2025-02-25
PublicationDate_xml – month: 02
  year: 2025
  text: 2025-02-25
  day: 25
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Pharmaceuticals (Basel, Switzerland)
PublicationTitleAlternate Pharmaceuticals (Basel)
PublicationYear 2025
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Iacobellis (ref_17) 2005; 53
Tariq (ref_11) 2019; 134
ref_14
Murray (ref_3) 2022; 399
ref_13
ref_12
Ionescu (ref_19) 2011; 59
ref_10
Johri (ref_24) 2011; 5
ref_18
Maurya (ref_16) 2022; 36
Janssen (ref_26) 1987; 53
Aly (ref_15) 2023; 99
Magiorakos (ref_20) 2012; 18
ref_23
ref_22
Kalemba (ref_27) 2003; 10
ref_1
Arendrup (ref_21) 2017; 216
ref_2
ref_29
Chen (ref_25) 2024; 40
ref_9
ref_8
ref_4
Fisher (ref_5) 2022; 20
ref_7
ref_6
Sampers (ref_28) 2019; 59
References_xml – ident: ref_7
  doi: 10.3390/antibiotics9060346
– ident: ref_2
  doi: 10.3390/antibiotics11091215
– volume: 134
  start-page: 103580
  year: 2019
  ident: ref_11
  article-title: A Comprehensive Review of the Antibacterial, Antifungal and Antiviral Potential of Essential Oils and Their Chemical Constituents Against Drug-Resistant Microbial Pathogens
  publication-title: Microb. Pathog.
  doi: 10.1016/j.micpath.2019.103580
– volume: 10
  start-page: 813
  year: 2003
  ident: ref_27
  article-title: Antibacterial and Antifungal Properties of Essential Oils
  publication-title: Curr. Med. Chem.
  doi: 10.2174/0929867033457719
– volume: 99
  start-page: 318
  year: 2023
  ident: ref_15
  article-title: Phytochemical Constitutes and Biological Activities of Essential Oil Extracted from Irradiated Caraway Seeds (Carum carvi L.)
  publication-title: Int. J. Radiat. Biol.
  doi: 10.1080/09553002.2022.2078004
– ident: ref_1
– ident: ref_6
  doi: 10.3390/jof3040057
– ident: ref_18
  doi: 10.3390/antibiotics12030591
– volume: 59
  start-page: 357
  year: 2019
  ident: ref_28
  article-title: A Review on Influencing Factors On the Minimum Inhibitory Concentration of Essential Oils
  publication-title: Crit. Rev. Food Sci. Nutr.
  doi: 10.1080/10408398.2017.1371112
– ident: ref_14
  doi: 10.3390/molecules26123625
– ident: ref_23
– volume: 59
  start-page: 440
  year: 2011
  ident: ref_19
  article-title: Screening of the antibacterial and antifungal activity of eight volatile essential oils
  publication-title: Farm. J.
– volume: 36
  start-page: 4563
  year: 2022
  ident: ref_16
  article-title: Mechanistic Investigations on Antifungal and Antiaflatoxigenic Activities of Chemically Characterised Carum carvi L. Essential Oil Against Fungal Infestation and Aflatoxin Contamination of Herbal Raw Materials
  publication-title: Nat. Prod. Res.
  doi: 10.1080/14786419.2021.1994566
– volume: 53
  start-page: 395
  year: 1987
  ident: ref_26
  article-title: Antimicrobial Activity of Essential Oils: A 1976–1986 Literature Review. Aspects of the Test Methods
  publication-title: Planta Med.
  doi: 10.1055/s-2006-962755
– ident: ref_8
– ident: ref_12
  doi: 10.3390/antiox10020330
– volume: 53
  start-page: 57
  year: 2005
  ident: ref_17
  article-title: Antibacterial Activity of Cuminum cyminum L. and Carum carvi L. Essential Oils
  publication-title: J. Agric. Food Chem.
  doi: 10.1021/jf0487351
– ident: ref_4
– ident: ref_10
  doi: 10.1016/j.ijmm.2020.151435
– ident: ref_29
– volume: 399
  start-page: 629
  year: 2022
  ident: ref_3
  article-title: Global Burden of Bacterial Antimicrobial Resistance in 2019: A Systematic Analysis
  publication-title: Lancet
  doi: 10.1016/S0140-6736(21)02724-0
– volume: 40
  start-page: 3445
  year: 2024
  ident: ref_25
  article-title: Minimum Inhibitory Concentration (MIC) of Essential Oils Against Microorganisms: Methods, Function, Accuracy Factors and Application
  publication-title: Food Rev. Int.
  doi: 10.1080/87559129.2024.2357612
– volume: 20
  start-page: 557
  year: 2022
  ident: ref_5
  article-title: Tackling the Emerging Threat of Antifungal Resistance to Human Health
  publication-title: Nat. Rev. Microbiol.
  doi: 10.1038/s41579-022-00720-1
– ident: ref_13
  doi: 10.3390/foods12214017
– volume: 5
  start-page: 63
  year: 2011
  ident: ref_24
  article-title: Cuminum cyminum and Carum carvi: An Update
  publication-title: Pharmacogn. Rev.
  doi: 10.4103/0973-7847.79101
– ident: ref_22
– volume: 18
  start-page: 268
  year: 2012
  ident: ref_20
  article-title: Multidrug-Resistant, Extensively Drug-Resistant and Pandrug-Resistant Bacteria: An International Expert Proposal for Interim Standard Definitions for Acquired Resistance
  publication-title: Clin. Microbiol. Infect.
  doi: 10.1111/j.1469-0691.2011.03570.x
– ident: ref_9
  doi: 10.3390/antibiotics10040417
– volume: 216
  start-page: S445
  year: 2017
  ident: ref_21
  article-title: Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment
  publication-title: J. Infect. Dis.
  doi: 10.1093/infdis/jix131
SSID ssj0057141
Score 2.3568833
Snippet Background/Objectives: In recent years, antimicrobial resistance has become a major threat to global health, and scientific research aiming to identify new...
: In recent years, antimicrobial resistance has become a major threat to global health, and scientific research aiming to identify new therapeutic resources is...
Background/Objectives : In recent years, antimicrobial resistance has become a major threat to global health, and scientific research aiming to identify new...
Background/Objectives : In recent years, antimicrobial resistance has become a major threat to global health, and scientific research aiming to identify new...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 321
SubjectTerms Antibiotics
Antifungal agents
Antimicrobial agents
Bacteria
broth microdilution test
Caraway
Chromatography
disk diffusion test
DMSO
Dosage and administration
Drug resistance
Drug resistance in microorganisms
E coli
Essences and essential oils
ethanol
Fungal infections
Health aspects
Herbal medicine
Mass spectrometry
Metabolism
microatmosphere test
Microorganisms
Oils & fats
Pathogens
Prevention
Scientific imaging
Staphylococcus infections
Tween80
SummonAdditionalLinks – databaseName: Open Access资源_DOAJ
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELbQnrgg3gQWNAi0XDbaOM7DOXarVrtIQAW7aG-R7ThspN2katJD_yK_ipk4fUQcuHCtp40df5n5pvF8w9hHrjk9Qqkfp_TXTSyoWLlI_TRQIsxKDBKS6p2_fE0urqPPN_HNQasvOhPm5IHdjTsTViMrKBMZSR2JopBKY4zLwkJlGNuDPlvHmLdNppwPjlMecSdGKtDobHnLJaJZhHwUfnqV_r998UEwGh-UPIg888fs0UAZYeKm-oQ9sPVTdrJwmtObU7jal1C1p3ACi70a9eYZ-31Zw8-qWzVARwY30DUwcwrfFpD8wTlOBaYNvbkmBAId_LijjB1jWm8wqbvqvur1mmgWxrWbgKaEqVqt78Eo9DYwa6mKiSy-VXfQ1NC_HYAFEswGMQqXiHGitVDVMEeePHQNa2HyS1VIUftL_VgihS3op-miumpwSfDdtsRxEZzP2fV8djW98IcGDr6JA975RppCZMqmIi0w08xKo5WyIW5hRJ0AtSkTdG8JDUYi0YmwskjKkJdlGBqZKfGCHdVNbV8xCMrCmiTRaZyUEVIqFSiSspOB0RnmiIXHPmz3NV86nY4c8xva_Xy_-x47py3fWZC2dv8BIi4fEJf_C3Ee-0SAyckDICqMGgoZcKKkpZVPJGb9nIibx45HlvjkmvHwFnL54DnaHH0sknDK1D32fjdM36TTcLVt1s5G0qnC0GMvHUJ3S4pIsBGn6zE5wu5ozeORurrtdcU5z6I4i9PX_-MuvWEPQ2qVTNX_8TE76lZr-xb5W6ff9Y_qH9YJRfg
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9NAEF5BeuGCeONS0CBQudSq7fVjfUJJlKpFokSlRb1Z-7BbS603xM4hf5FfxYztJLWQuGbX8Vr77ew3uzPfMPbZVz4tocSNEjq6iTglK5vETTzJg7TATUJQvvP38_j0Kvx2HV33B251H1a5sYmtoTZW0xn5MWIPyQl5MF8Xv12qGkW3q30JjcdsD02wECO2N5mdzy82tjhK_NDvREk5OvfHi1tfIKp54A-2oVat_1-b_GBTGgZMPtiBTp6xpz11hHE318_Zo7x6wQ7nnfb0-ggud6lU9REcwnynSr1-yf6cVfCrbJYWKHRwDY2FWaf0nQOSQJjgUGBq6QabkAgUAHJHnjvubW2HcdWU92Wr20Sj0F3ZCbAFTOVydQ9aotWBWU3ZTNTjR3kHtoL2lgDmSDQtYhXOEOtEb6Gs4AT5cl89rIbxjSyRqrav-rlAKmvor-mlqrT4SXCR18R1EaSv2NXJ7HJ66vaFHFwdeX7jaqENT2We8MSgx5kWWkmZB0KqkCoCKl3EaOZiagx5rGKeCxMXgV8UQaBFKvlrNqpslb9l4BUm13GskiguQqRW0pMkaSc8rVL0FY3DPm3mNVt0eh0Z-jk0-9lu9h02oSnf9iCN7fYHu7zJ-iWb8VwhHy1iEQoVcmNwuMiu0sDIFFml5znsCwEmI0uAqNCyT2jAgZKmVjYW6P37ROAcdjDoiStYD5s3kMt6C1JnO7w77OO2mZ6kqLgqt6uuj6DowsBhbzqEbj8pJOFGHK7DxAC7g28etlTlbasv7vtpGKVRsv__cb1jTwIqhkz5_dEBGzXLVf4eGVqjPvTL8C-6Dz9Q
  priority: 102
  providerName: ProQuest
Title In Vitro Study to Evaluate the Best Conditions Highlighting the Antimicrobial Activity of Carum carvi Essential Oil on Human Pathogen Isolates in Formulations Against the Spread of Antibiotic Resistance
URI https://www.ncbi.nlm.nih.gov/pubmed/40143099
https://www.proquest.com/docview/3181610106
https://www.proquest.com/docview/3181820032
https://pubmed.ncbi.nlm.nih.gov/PMC11945957
https://doaj.org/article/3eb085f6848b43dd8ab50992da983900
Volume 18
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELem7YUXxDcZozoEGi8rJHE-nAeE2qrVhrRRjRXtLbIdZ4vUJSVNJfov8ldxl6TtAjzxGl8SO77z_S72_Y6xd45yyITCvh_SrxufU7JyEvZDW3I3StFJCMp3Pr8ITmfel2v_eo9t6ne2H3D5z9CO6knNyvmHnz_Wn9HgP1HEiSH7x8WtI1BXOeWTH6BHCqmSwbm33U3wQ8dzGmrSP-Q7zqjm7P97Zb7nmrrHJu_5ockj9rAFkDBoZvwx2zP5E3Y8bRio1ydwtUuoWp7AMUx33NTrp-zXWQ7fs6osgA4QrqEqYNzwfRtAKAhD7AqMCtrHJn0EOgYyp_gdPVwtMMir7C6r2ZuoF7opPgFFCiNZru5AS1x7YLyknCaS-JrNocih3iuAKcLNAjUWzlDjCeRClsMEUXNbQ2wJgxuZIWCtX_VtgYA2oUfTS1VW4JDg0iwJ8aKqPmOzyfhqdNpvyzn0tW87VV8LnfBImpCHCcadUaqVlMYVUnlUF1DpNMDFLqBGjwcq4EYkQeo6aeq6WkSSP2f7eZGblwzsNDE6CFToB6mHAEvakojthK1VhBFjYrG3m3mNFw1rR4zRDs1-vJt9iw1pyrcSxLRdXyjKm7g13Jgbhag0DYQnlMeTBLuLGCtyExkhtrRti70nhYlJQ1ErtGzTGrCjxKwVDwQX3CEYZ7GjjiTase42b1Qu3phBjCsuQnKK2y32ZttMd9LZuNwUq0ZG0BlD12IvGg3dDskj-kbsrsVER3c7Y-625NltzTLuOJHnR354-P-3vmIPXCqXTAwA_hHbr8qVeY0YrlI9djAcX0wve_U_kF5trr8BXcdONg
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6V9AAXxBtDgUFAudSq7fVjfUAoCYkS2oaotFVvZr22W0utHRJHKH-KH8KvYsaPpBYSt16zG3uteX27O_MNY-_N0CQT8nTHo6Mbh1OxcuTpniG55ScYJATVOx9N3NGp_fXcOd9iv5taGEqrbHxi6aijXNEZ-T7qHoIT2sF8nv3UqWsU3a42LTQqtTiIV79wy7b4NP6C8v1gWcPBSX-k110FdOUYZqEroSLuy9jjXoTbHz9RoZSxJWRoU3u6UCUu2pxLgzZ3Q5fHInITy0wSy1LClxyfe4dt45hhddh2bzCZHje-3_FM26xIUDn3jf3ZpSnQirhltsJe2R3g3xhwIwi2EzRvRLzhA3a_hqrQrXTrIduKs0dsd1pxXa_24GRTurXYg12YbliwV4_Zn3EGZ2kxz4FSFVdQ5DComMVjQNAJPVwK9HO6MSfNB0o4uaKTAoyl5YRuVqTXackTRatQVZsLyBPoy_nyGpRELweDBVVP0Yxv6RXkGZS3EjBFYJujbcAYbYvgNKQZDBGf193KFtC9kClC4_JV32cInSN6NL00THP8JDiOF4St0SiesNNbEfFT1snyLH7OwEiiWLlu6DluYiOUk4YkCj1hqNDHvWmksXeNXINZxQ8S4L6KpB9spK-xHol8PYM4vcsf8vlFULuIgMch4t_EFbYIbR5FuFxEc74VSR9RrGFo7CMpTECeB7VCybqAAhdKHF5BV3DBTQKMGttpzUSPodrDjcoFtcdaBBv70tjb9TD9k7LwsjhfVnMEZTNaGntWaej6k2wiisTlaky0dLf1ze2RLL0s-cxN07cd3_Fe_H9db9jd0cnRYXA4nhy8ZPcsasRM3ALODusU82X8CtFhEb6uTRLYj9v2An8BC4980Q
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VVEJcEG8MBQYB5VIrtteP9QGhJE3UUChRaVFvZr22W0utHWJHKH-Nn8CvYsaPpBYSt16zG3useX2zOw_G3pqhSSrk6Y5HRzcOp2LlyNM9Q3LLT9BJCKp3_nLkHpzan86csy32u62FobTK1iZWhjrKFZ2R91H2EJxQBNNPmrSI2f7k4_ynThOk6Ka1HadRi8hhvPqF4VvxYbqPvH5nWZPxyehAbyYM6MoxzFJXQkXcl7HHvQhDIT9RoZSxJWRo06i6UCUu6p9LizZ3Q5fHInITy0wSy1LClxyfe4ttexQV9dj2cHw0O279gOOZtlk3ROXcN_rzC1OgRnHL7LjAalLAv_7gmkPsJmte836Te-xuA1thUMvZfbYVZw_Y7qzue73ag5NNGVexB7sw23TEXj1kf6YZfE_LRQ6UtriCModx3WU8BgSgMERSYJTT7TlpAVDyySWdGqBfrTYMsjK9SqueUUSFqkdeQJ7ASC6WV6AkWjwYF1RJRTu-ppeQZ1DdUMAMQW6OegJT1DOC1pBmMEGs3kwuK2BwLlOEydWrvs0RRkf0aHppmOb4SXAcF4SzUUEesdMbYfFj1svyLH7KwEiiWLlu6DluYiOsk4akdnrCUKGPcWqksTctX4N53SskwBiLuB9suK-xIbF8vYP6e1c_5IvzoDEXAY9DxMKJK2wR2jyKkFxEdr4VSR8RrWFo7D0JTEBWCKVCyaaYAgmlfl7BQHDBTQKPGtvp7ETrobrLrcgFjfUqgo2uaez1epn-SRl5WZwv6z2CMhstjT2pJXT9STY1jURyNSY6stv55u5Kll5Uvc1N07cd3_Ge_Z-uV-w2an_weXp0-JzdsWgmM7UZcHZYr1ws4xcIFMvwZaORwH7ctBH4C42dgQY
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=In+Vitro+Study+to+Evaluate+the+Best+Conditions+Highlighting+the+Antimicrobial+Activity+of+Carum+carvi+Essential+Oil+on+Human+Pathogen+Isolates+in+Formulations+Against+the+Spread+of+Antibiotic+Resistance&rft.jtitle=Pharmaceuticals+%28Basel%2C+Switzerland%29&rft.au=Mastrella%2C+Carolina&rft.au=Rizzo%2C+Silvia&rft.au=Vito%2C+Maura+Di&rft.au=Garzoli%2C+Stefania&rft.date=2025-02-25&rft.pub=MDPI&rft.eissn=1424-8247&rft.volume=18&rft.issue=3&rft_id=info:doi/10.3390%2Fph18030321&rft.externalDocID=PMC11945957
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1424-8247&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1424-8247&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1424-8247&client=summon